In a first, the World Health Organisation (WHO) on Wednesday prequalified the hepatitis C virus (HCV) self-test that will help expand access to testing and diagnosis and accelerate global efforts to eliminate the disease.Hepatitis is an inflammation of the liver caused by a variety of infectious viruses and non-infectious agents leading to a range of health problems.An estimated 354 million people worldwide live with hepatitis B or C, and for most, testing and treatment remain beyond reach.
The new product, called OraQuick HCV self-test, manufactured by US-based OraSure Technologies is designed for use by anyone, without any expertise.
The WHO had, in 2021, recommended HCV self-testing (HCVST) to complement existing HCV testing services in countries, and may help increase access to and uptake of services, particularly among people who may not otherwise test.